The Multicomponent Medication Lymphomyosot Improves the Outcome of Experimental Lymphedema
Identifieur interne : 003096 ( Main/Merge ); précédent : 003095; suivant : 003097The Multicomponent Medication Lymphomyosot Improves the Outcome of Experimental Lymphedema
Auteurs : Alex P. Keim ; Justin R. Slis ; Uziel Mendez ; Emily M. Stroup ; Yvonne Burmeister ; Natalie Tsolaki ; Oliver Gailing ; Jeremy GoldmanSource :
- Lymphatic Research and Biology [ 1539-6851 ] ; 2013.
Descripteurs français
- KwdFr :
- MESH :
- anatomopathologie : Lymphoedème, Macrophages.
- traitement médicamenteux : Lymphoedème.
- usage thérapeutique : Extraits de plantes.
- Animaux, Cicatrisation de plaie, Femelle, Modèles animaux de maladie humaine, Souris, Souris de lignée BALB C.
English descriptors
- KwdEn :
- MESH :
- chemical , therapeutic use : Plant Extracts.
- drug therapy : Lymphedema.
- pathology : Lymphedema, Macrophages.
- Animals, Disease Models, Animal, Female, Mice, Mice, Inbred BALB C, Wound Healing.
Abstract
Secondary lymphedema is a life-long disease of painful tissue swelling that often follows axillary lymph node dissection to treat breast cancer. It is hypothesized that poor lymphatic regeneration across the obstructive scar tissue during the wound healing process may predispose the tissue to swell at a later date. Treatment for lymphedema remains suboptimal and is in most cases palliative. The purpose of this study was to evaluate the ability of Lymphomyosot to treat tissue swelling and promote lymphangiogenesis in experimental models of murine lymphedema.
Experimental models of mouse lymphedema were injected with varied amounts of Lymphomyosot and saline as control. Measurements of tail swelling and wound closure were taken and compared amongst the groups. Three separate groups of mice were analyzed for lymphatic capillary migration, lymphatic vessel regeneration, and macrophage recruitment.
Lymphomyosot significantly reduced swelling and increased the rate of surgical wound closure. Lymphomyosot did not increase the migration of lymph capillaries in a mouse tail skin regeneration model or regeneration of lymph vessels following murine axillary lymph node dissection.
Lymphomyosot may act through inflammatory and wound repair pathways to reduce experimental lymphedema. Its ability to regulate inflammation as well as assist in tissue repair and extracellular formation may allow for the production of a scar-free matrix bridge through which migrating cells and accumulated interstitial fluid can freely spread.
Url:
DOI: 10.1089/lrb.2012.0024
PubMed: 23725444
PubMed Central: 3696932
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 003025
- to stream Pmc, to step Curation: 003024
- to stream Pmc, to step Checkpoint: 001F26
- to stream PubMed, to step Corpus: 001B10
- to stream PubMed, to step Curation: 001B10
- to stream PubMed, to step Checkpoint: 001B10
- to stream Ncbi, to step Merge: 005973
- to stream Ncbi, to step Curation: 005973
- to stream Ncbi, to step Checkpoint: 005973
Links to Exploration step
PMC:3696932Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The Multicomponent Medication Lymphomyosot Improves the Outcome of Experimental Lymphedema</title>
<author><name sortKey="Keim, Alex P" sort="Keim, Alex P" uniqKey="Keim A" first="Alex P." last="Keim">Alex P. Keim</name>
<affiliation><nlm:aff id="aff1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Slis, Justin R" sort="Slis, Justin R" uniqKey="Slis J" first="Justin R." last="Slis">Justin R. Slis</name>
<affiliation><nlm:aff id="aff1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Mendez, Uziel" sort="Mendez, Uziel" uniqKey="Mendez U" first="Uziel" last="Mendez">Uziel Mendez</name>
<affiliation><nlm:aff id="aff1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Stroup, Emily M" sort="Stroup, Emily M" uniqKey="Stroup E" first="Emily M." last="Stroup">Emily M. Stroup</name>
<affiliation><nlm:aff id="aff1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Burmeister, Yvonne" sort="Burmeister, Yvonne" uniqKey="Burmeister Y" first="Yvonne" last="Burmeister">Yvonne Burmeister</name>
<affiliation><nlm:aff id="aff3"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Tsolaki, Natalie" sort="Tsolaki, Natalie" uniqKey="Tsolaki N" first="Natalie" last="Tsolaki">Natalie Tsolaki</name>
<affiliation><nlm:aff id="aff4"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Gailing, Oliver" sort="Gailing, Oliver" uniqKey="Gailing O" first="Oliver" last="Gailing">Oliver Gailing</name>
<affiliation><nlm:aff id="aff2"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Goldman, Jeremy" sort="Goldman, Jeremy" uniqKey="Goldman J" first="Jeremy" last="Goldman">Jeremy Goldman</name>
<affiliation><nlm:aff id="aff1"></nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">23725444</idno>
<idno type="pmc">3696932</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3696932</idno>
<idno type="RBID">PMC:3696932</idno>
<idno type="doi">10.1089/lrb.2012.0024</idno>
<date when="2013">2013</date>
<idno type="wicri:Area/Pmc/Corpus">003025</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">003025</idno>
<idno type="wicri:Area/Pmc/Curation">003024</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">003024</idno>
<idno type="wicri:Area/Pmc/Checkpoint">001F26</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">001F26</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="wicri:Area/PubMed/Corpus">001B10</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001B10</idno>
<idno type="wicri:Area/PubMed/Curation">001B10</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001B10</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001B10</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001B10</idno>
<idno type="wicri:Area/Ncbi/Merge">005973</idno>
<idno type="wicri:Area/Ncbi/Curation">005973</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">005973</idno>
<idno type="wicri:doubleKey">1539-6851:2013:Keim A:the:multicomponent:medication</idno>
<idno type="wicri:Area/Main/Merge">003096</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">The Multicomponent Medication Lymphomyosot Improves the Outcome of Experimental Lymphedema</title>
<author><name sortKey="Keim, Alex P" sort="Keim, Alex P" uniqKey="Keim A" first="Alex P." last="Keim">Alex P. Keim</name>
<affiliation><nlm:aff id="aff1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Slis, Justin R" sort="Slis, Justin R" uniqKey="Slis J" first="Justin R." last="Slis">Justin R. Slis</name>
<affiliation><nlm:aff id="aff1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Mendez, Uziel" sort="Mendez, Uziel" uniqKey="Mendez U" first="Uziel" last="Mendez">Uziel Mendez</name>
<affiliation><nlm:aff id="aff1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Stroup, Emily M" sort="Stroup, Emily M" uniqKey="Stroup E" first="Emily M." last="Stroup">Emily M. Stroup</name>
<affiliation><nlm:aff id="aff1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Burmeister, Yvonne" sort="Burmeister, Yvonne" uniqKey="Burmeister Y" first="Yvonne" last="Burmeister">Yvonne Burmeister</name>
<affiliation><nlm:aff id="aff3"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Tsolaki, Natalie" sort="Tsolaki, Natalie" uniqKey="Tsolaki N" first="Natalie" last="Tsolaki">Natalie Tsolaki</name>
<affiliation><nlm:aff id="aff4"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Gailing, Oliver" sort="Gailing, Oliver" uniqKey="Gailing O" first="Oliver" last="Gailing">Oliver Gailing</name>
<affiliation><nlm:aff id="aff2"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Goldman, Jeremy" sort="Goldman, Jeremy" uniqKey="Goldman J" first="Jeremy" last="Goldman">Jeremy Goldman</name>
<affiliation><nlm:aff id="aff1"></nlm:aff>
</affiliation>
</author>
</analytic>
<series><title level="j">Lymphatic Research and Biology</title>
<idno type="ISSN">1539-6851</idno>
<idno type="eISSN">1557-8585</idno>
<imprint><date when="2013">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Disease Models, Animal</term>
<term>Female</term>
<term>Lymphedema (drug therapy)</term>
<term>Lymphedema (pathology)</term>
<term>Macrophages (pathology)</term>
<term>Mice</term>
<term>Mice, Inbred BALB C</term>
<term>Plant Extracts (therapeutic use)</term>
<term>Wound Healing</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term>
<term>Cicatrisation de plaie</term>
<term>Extraits de plantes (usage thérapeutique)</term>
<term>Femelle</term>
<term>Lymphoedème (anatomopathologie)</term>
<term>Lymphoedème (traitement médicamenteux)</term>
<term>Macrophages (anatomopathologie)</term>
<term>Modèles animaux de maladie humaine</term>
<term>Souris</term>
<term>Souris de lignée BALB C</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Plant Extracts</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Lymphoedème</term>
<term>Macrophages</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Lymphedema</term>
<term>Macrophages</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Extraits de plantes</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Disease Models, Animal</term>
<term>Female</term>
<term>Mice</term>
<term>Mice, Inbred BALB C</term>
<term>Wound Healing</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Animaux</term>
<term>Cicatrisation de plaie</term>
<term>Femelle</term>
<term>Modèles animaux de maladie humaine</term>
<term>Souris</term>
<term>Souris de lignée BALB C</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><title>Abstract</title>
<sec><title>Background</title>
<p>Secondary lymphedema is a life-long disease of painful tissue swelling that often follows axillary lymph node dissection to treat breast cancer. It is hypothesized that poor lymphatic regeneration across the obstructive scar tissue during the wound healing process may predispose the tissue to swell at a later date. Treatment for lymphedema remains suboptimal and is in most cases palliative. The purpose of this study was to evaluate the ability of Lymphomyosot to treat tissue swelling and promote lymphangiogenesis in experimental models of murine lymphedema.</p>
</sec>
<sec><title>Methods</title>
<p>Experimental models of mouse lymphedema were injected with varied amounts of Lymphomyosot and saline as control. Measurements of tail swelling and wound closure were taken and compared amongst the groups. Three separate groups of mice were analyzed for lymphatic capillary migration, lymphatic vessel regeneration, and macrophage recruitment.</p>
</sec>
<sec><title>Results</title>
<p>Lymphomyosot significantly reduced swelling and increased the rate of surgical wound closure. Lymphomyosot did not increase the migration of lymph capillaries in a mouse tail skin regeneration model or regeneration of lymph vessels following murine axillary lymph node dissection.</p>
</sec>
<sec><title>Conclusions</title>
<p>Lymphomyosot may act through inflammatory and wound repair pathways to reduce experimental lymphedema. Its ability to regulate inflammation as well as assist in tissue repair and extracellular formation may allow for the production of a scar-free matrix bridge through which migrating cells and accumulated interstitial fluid can freely spread.</p>
</sec>
</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003096 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 003096 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Main |étape= Merge |type= RBID |clé= PMC:3696932 |texte= The Multicomponent Medication Lymphomyosot Improves the Outcome of Experimental Lymphedema }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/RBID.i -Sk "pubmed:23725444" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |